Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding of Aclidinium/Formoterol in COPD
NCT00626522Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of aclidinium, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Feb 2008; status: completed.
02
Drugs
aclidiniumformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00626522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626522.